Found 41 matching trials
Safety, Efficacy and Pharmacokinetics of ALD403
PHASE1The purpose of this study is to assess the safety, pharmacokinetics and eff...
Location
Premiere Research
A Study to Evaluate the Efficacy and Safety of Eptinezumab Administered Intravenously in Participants Experiencing Acute Attack of Migraine
PHASE3The purpose of this study is to evaluate the efficacy and safety of eptinez...
Location
Alabama Clinical Therapeutics
A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
PHASE3The main goal of the study is to assess the long-term safety of eptinezumab...
Location
Yale University School of Medicine
Effectiveness and Tolerability of Eptinezumab
N/AThe purpose of this prospective and multicentric study is to evaluate the e...
Migraine Induction Properties of PACAP-38 After Eptinezumab in Migraine Without Aura Patients.
NATo investigate whether administration of calcitonin gene-related peptide (C...
Location
Danish headache center
Eptinezumab for Chronic Headache in Idiopathic Intracranial Hypertension
PHASE3The goal of this clinical trial is to learn if eptinezumab can reduce heada...
Location
Multiple Locations
Study for Prevent Chronification Migraine Through Prediction of Response to Treatment With Anti-CGRP Antibodies
N/ABeing able to predict each patients response to a specific treatment can me...
Location
Hospital Clínico Universitario Lozano Blesa
Eptinezumab in Adults With Migraine and Medication Overuse Headache
PHASE3This study evaluates the efficacy of eptinezumab to prevent migraine and he...
Location
The First Affiliated Hospital of Guangzhou Medical University
A 1-year Trial to Inform About Long-term Exposure to Eptinezumab in Participants With Chronic Cluster Headache (cCH)
PHASE3The main goal of this trial is to inform about long-term safety and tolerab...
Location
New England Institute for Neurology and Headache
Real World Effectiveness of Eptinezumab in Participants With Migraine
PHASE4The purpose of this study is to examine how eptinezumab compares to other a...
Location
Gilbert Neurology Partners/ CCT Research